Axis Securities initiates coverage on Fortis Healthcare with a buy rating. The target price is Rs 860. Fortis' strong revenue growth and financial performance support this positive outlook. Improving occupancies and rising ARPOB will boost profitability. Brownfield expansions and leadership in key therapies will drive growth. The target price offers a 20% upside potential.
